Patent · US Active

1,4-benzothiazepine 1,1-dioxide derivative, process for its preparation, medicaments comprising this compound, and use thereof as a hypolipidaemic

US7615536B2 · kind B2 · utility

35Cited by

2References

17Claims

0Family size

Assignee

Sanofi-Aventis Deutschland GMBH · DE

Inventors

Wendelin Frick · Bad Camberg, DE
Heiner Glombik · Hofheim, DE
Hubert Heuer · Frankfurt am Main, DE
Hans-Ludwig Schaefer · Frankfurt am Main, DE
Stefan Theis · Frankfurt, DE

Key dates

Filing date	Jan 7, 2008
Grant date	Nov 10, 2009
Priority date	—
Expiry date	Apr 24, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the compound of the formula (A) and also to its physiologically acceptable salts. The compound is suitable as, for example, a hypolipidemic

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.